VASOPRESSIN IN SODIUM CHLORIDE 0.9%
VASOPRESSIN
Approval overview VASOPRESSIN IN SODIUM CHLORIDE 0.9% is listed in Drugs@FDA under application 217766 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VASOPRESSIN Form and strength SOLUTION;INTRAVENOUS - 40UNITS/100ML (0.4UNITS/ML) Sponsor LONG GROVE PHARMS Submission history Latest submission status date: 2024-07-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview VASOPRESSIN IN SODIUM CHLORIDE 0.9% is listed in Drugs@FDA under application 217766 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VASOPRESSIN Form and strength SOLUTION;INTRAVENOUS - 40UNITS/100ML (0.4UNITS/ML) Sponsor LONG GROVE PHARMS Submission history Latest submission status date: 2024-07-11 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.